IP Library Granted Patent US 7,166,574
Granted Patent B2
US 7,166,574 · App. 10/224,268 · Granted Jan 23, 2007

Synthetic heparin-binding growth factor analogs

Assignees: BioSurface Engineering Technologies, Inc.; Brookhaven National Laboratory
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,166,574
App. No.
10/224,268
Granted
Jan 23, 2007
Kind
B2
Abstract

The invention provides synthetic heparin-binding growth factor analogs having at least one peptide chain that binds a heparin-binding growth factor receptor, covalently bound to a hydrophobic linker, which is in turn covalently bound to a non-signaling peptide that includes a heparin-binding domain. The synthetic heparin-binding growth factor analogs are useful as soluble biologics or as surface coatings for medical devices.

Claims (21)

1. A synthetic heparin-binding growth factor (HBGF) analog comprising a molecule having the formula (I):

wherein each X represents YRSRKYSSWYVALKR (SEQ ID NO:3), and

n is 1;

J 1 represents an amino acid;

J 2 represents a-diamino acid;

Y represents a linker that (i) is sufficiently hydrophobic to bind non-covalently to a polystyrene or polycaprolactone surface, (ii) comprises a chain of a minimum of about three and a maximum of about 17 residues, (iii) is not found in the natural ligand of the heparin-binding growth factor receptor (HBGFR), and (iv) is covalently bonded to J 2 and Z; and

Z represents a peptide that comprises a heparin binding domain, comprising RKRKLERAIR (SEQ ID NO:2) and

wherein the peptide analog has an avidity for heparin such that the synthetic heparin-binding growth factor analog binds heparin in 0.48M NaCl, but is eluted by 1M NaCl.

2. A synthetic heparin-binding growth factor analog according to claim 1 , consisting of a molecule of formula (I).

3. A synthetic heparin-binding growth factor analog according to claim 1 , wherein binding of the synthetic heparin-binding growth factor analog to the heparin-binding growth factor receptor initiates a signal by the heparin-binding growth factor receptor.

4. A synthetic heparin-binding growth factor analog according to claim 1 , wherein binding of the synthetic peptide to the heparin-binding growth factor receptor blocks signaling by the heparin-binding growth factor receptor.

5. A synthetic heparin-binding growth factor analog according to claim 1 , wherein J 1 and/or J 2 is an α-amino acid.

6. A synthetic heparin-binding growth factor analog according to claim 1 , wherein J 2 is lysine.

7. A synthetic heparin-binding growth factor (HBGF) analog comprising a molecule having the formula (I):

wherein each X represents YRSRKYSSWYVALKR (SEQ ID NO:3), and

n is 1;

J 1 represents lysine;

J 2 represents lysine;

Y represents a linker covalently bonded to J 2 and Z; and

Z represents a heparin binding sequence comprising RKRKLERAIR (SEQ ID NO:2).

8. The analog of claim 7 wherein Y is Hex-Hex-Hex (aminohexanoic acid tripeptide).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2015
From: FERRING INTERNATIONAL CENTER S.A.
To: FERRING B.V.
Reel/Frame 036062/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2015
From: BIOSURFACE ENGINEERING TECHNOLOGIES, INC.
To: FERRING INTERNATIONAL CENTER S.A.
Reel/Frame 035769/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2002
From: ZAMORA, PAUL
To: BIOSURFACE ENGINEERING TECHNOLOGIES, INC.
Reel/Frame 013575/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2002
From: PENA, LOUIS A.; LIN, XINHUA; GLASS, JOHN D.
To: BROOKHAVEN SCIENCE ASSOCIATES
Reel/Frame 013595/0888 →
Continuity (1)
Related Publication 20040038348A1 · Feb 26, 2004